Takayasu arteritis: an update
Takayasu arteritis: an update
Turk J Med Sci. 2018 Aug 16;48(4):681-697
Authors: Keser G, Aksu K, Direskeneli H
Abstract
Takayasu arteritis (TAK) is a challenging chronic, granulomatous, large-vessel systemic vasculitis, mostly due to difficulties in
early diagnosis and assessing actual disease activity. Since there are no specific diagnostic laboratory tests, biomarkers, or autoantibodies,
many patients experience considerable delay in diagnosis. Remembering the possibility of TAK together with the use of acute phase
responses and appropriate imaging studies may be helpful for early diagnosis. Since there may be discrepancies between systemic and
vascular wall inflammation, using only acute phase responses is not reliable in assessing current disease activity. Therefore, physical
examination and new imaging findings should also be used to assess current disease activity. Despite its limitations, the Indian Takayasu
Clinical Activity Score (ITAS2010) may also be helpful for this purpose. The rationale of medical treatment is to suppress both vascular and
systemic inflammation with appropriate systemic immunosuppression, including corticosteroids and conventional immunosuppressive
agents. In cases of refractory disease activity, leflunomide and biologic agents such as TNF inhibitors and tocilizumab may be tried.
In selected cases with persistent lesions that cannot be reversed with medica...
Source: Turkish Journal of Medical Sciences - Category: General Medicine Tags: Turk J Med Sci Source Type: research
More News: Actemra | Angioplasty | Baloon Angioplasty | Corticosteroid Therapy | General Medicine | India Health | Laboratory Medicine | Study | Turkey Health | Vasculitis